Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
- 1 December 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (18), 3149-3156
- https://doi.org/10.1016/j.ejca.2006.08.015
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Typical medullary breast carcinomas have a basal/myoepithelial phenotypeThe Journal of Pathology, 2005
- Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal PhenotypeClinical Cancer Research, 2005
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical OutcomesClinical Cancer Research, 2004
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical OutcomeThe American Journal of Pathology, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000
- MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCERThe Lancet, 1987